Morgan Stanley
MS
$192.69
+0.09%
Morgan Stanley is a leading global financial services firm operating primarily in the Capital Markets industry, with core businesses spanning investment banking, institutional securities trading, wealth management, and asset management. The company has strategically transformed into a diversified financial institution, establishing itself as a dominant player in wealth and asset management, where it now oversees trillions in client assets, while maintaining a top-tier presence in its traditional investment banking and trading roots. The current investor narrative is focused on the firm's ability to leverage its diversified model to capitalize on market volatility, as evidenced by recent headlines highlighting a record trading quarter driven by geopolitical events, and the ongoing debate around the sustainability of its growth across its three key segments.…
MS
Morgan Stanley
$192.69
Related headlines
Investment Opinion: Should I buy MS Today?
Rating & Thesis: Morgan Stanley is a Hold. The core thesis is that the stock's high-quality business model and strong profitability are already reflected in its premium valuation near 52-week highs, leaving limited near-term upside without a new catalyst for earnings acceleration or multiple expansion. Analyst sentiment is stable but not overwhelmingly bullish, with firms like Barclays and KBW maintaining 'Overweight' ratings while JP Morgan is 'Neutral'.
Supporting Evidence: The hold rating is supported by a forward P/E of 15.15x, which is reasonable but not cheap, a solid but decelerating revenue growth rate of 11.08% YoY, and excellent profitability metrics like a 15.10% ROE and 19.09% operating margin. The stock's technical position at 97.5% of its 52-week high suggests it is fairly valued in the near term, having already priced in much of the positive momentum from its 45% one-year gain.
Risks & Conditions: The biggest risks to the thesis are a sharper-than-expected slowdown in capital markets revenue, compression of the premium P/E multiple, and sustained negative free cash flow. This Hold would upgrade to a Buy if the stock corrects meaningfully below $170 (offering a better entry point), or if quarterly revenue re-accelerates above 15% YoY. It would downgrade to a Sell if the debt-to-equity ratio escalates above 5.0 or if net margins contract below 12%. Relative to its history and the quality of its franchises, the stock is currently fairly valued.
Sign up to view all
MS 12-Month Price Forecast
Morgan Stanley is a high-quality franchise in a fair-value zone. The AI assessment is Neutral with Medium confidence. The firm's diversified model and wealth management strength provide a solid floor, but near-term upside is capped by valuation and cyclical headwinds for capital markets. The stance would upgrade to Bullish on a pullback to the $170-$175 range, which would improve the risk/reward profile significantly. Conversely, a breakdown below the $154 support level on deteriorating fundamentals would warrant a Bearish view. Investors should await a better entry point or clearer evidence of re-accelerating growth.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Morgan Stanley's 12-month outlook, with a consensus price target around $250.50 and implied upside of +30.0% versus the current price.
Average Target
$250.50
7 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
7
covering this stock
Price Range
$154 - $251
Analyst target range
Analyst coverage for Morgan Stanley is substantial, with 7 analysts providing estimates. The consensus sentiment leans bullish, as reflected in recent institutional ratings where firms like Barclays and Keefe, Bruyette & Woods maintain 'Overweight' or 'Outperform' ratings, while JP Morgan holds a 'Neutral' stance. The average target price is not explicitly provided in the analyst data, which contains revenue and EPS estimates but not price targets, therefore the implied upside or downside cannot be calculated from the given dataset. The target range and signal strength cannot be quantified due to the absence of specific price target data in the provided analyst dataset. However, the presence of multiple major firms providing ratings indicates strong institutional interest and coverage. The recent pattern of reaffirmations (e.g., Barclays and KBW maintaining Outperform in Q1 2026) suggests steady, positive conviction in the story, rather than a wave of upgrades or downgrades, which points to a stable analyst outlook.
Bulls vs Bears: MS Investment Factors
The investment debate for Morgan Stanley centers on the sustainability of its premium valuation against the backdrop of its powerful, diversified business model and strong profitability. Currently, the bull case appears to have stronger evidence, anchored by the firm's dominant wealth management franchise, robust margins, and long-term outperformance. However, the bear case is substantiated by concerning signals of revenue deceleration, elevated leverage, and negative cash flow. The single most important tension is whether the firm's high-quality, stable earnings from wealth management can continue to justify a valuation trading near the top of its historical range, especially if capital markets activity softens and limits overall growth. The resolution of this growth-vs-valuation dynamic will likely dictate the stock's path over the next 12 months.
Bullish
- Dominant Wealth & Asset Management: Morgan Stanley's strategic transformation has resulted in a dominant, fee-based wealth and asset management franchise overseeing $9.3 trillion in client assets. This provides a stable, recurring revenue stream that is less volatile than capital markets activities, underpinning the firm's robust 15.10% Return on Equity and justifying a valuation premium.
- Strong Profitability & Margin Stability: The firm consistently generates high profitability with a Q4 2025 net margin of 14.66% and an operating margin of 19.09%. Gross margins have remained stable between 54.7% and 58.7% over the last four quarters, demonstrating effective cost management and resilience despite revenue fluctuations.
- Outperforming Long-Term Momentum: The stock has delivered a +45.28% return over the past year, significantly outperforming the SPY's +25.19% gain. This sustained uptrend, coupled with a 3-month relative strength of +4.06%, reflects strong market conviction in the firm's diversified model and growth trajectory.
- Attractive Forward Valuation: Trading at a forward P/E of 15.15x, the valuation appears reasonable for a firm of its quality and growth profile. The PEG ratio of 0.58, based on trailing metrics, suggests the stock may be undervalued relative to its earnings growth potential.
Bearish
- Revenue Growth Deceleration: Q4 2025 revenue of $28.86 billion represents a sequential decline from Q3's $30.05 billion, indicating a potential peak in the recent cycle. While YoY growth was 11.08%, this deceleration raises questions about the sustainability of top-line momentum in a mixed capital markets environment.
- Elevated Valuation & Limited Multiple Expansion: The trailing P/E of 16.54x sits near the higher end of its historical range (8.5x to 24.7x), suggesting the market is pricing in optimistic expectations. This leaves little room for P/E multiple expansion and increases sensitivity to any earnings disappointment.
- Significant Negative Free Cash Flow: The firm reports a trailing twelve-month free cash flow of -$17.89 billion. While this is influenced by the nature of the banking business (e.g., loan growth, trading book changes), it represents a substantial cash outflow that requires careful monitoring for sustainability.
- High Financial Leverage: A debt-to-equity ratio of 4.26, while common for leveraged financial institutions, indicates a high degree of financial leverage. This amplifies risks during periods of rising interest rates or economic stress, potentially pressuring net interest margins and profitability.
MS Technical Analysis
The stock is in a sustained uptrend, evidenced by a 1-year price change of +45.28%, significantly outperforming the SPY's +25.19% gain. As of the latest close of $192.51, the stock is trading at approximately 97.5% of its 52-week high of $197.5, indicating it is near the top of its annual range and reflecting strong momentum, though also suggesting potential for near-term consolidation or profit-taking given the proximity to a major resistance level. Recent momentum shows a deceleration from the powerful longer-term trend, with a 1-month gain of only +0.46% and a 3-month gain of +12.48%, the latter of which still outpaces the SPY's +8.42% return. This divergence, where short-term momentum has cooled while the stock holds near highs, could signal a healthy pause or consolidation before a potential breakout, rather than a reversal, as evidenced by its positive relative strength of +4.06% over the last three months. Key technical support is anchored at the 52-week low of $123.88, while immediate resistance is the 52-week high of $197.5. A decisive breakout above $197.5 would signal a continuation of the primary bull trend, while a failure and reversal could see a test of lower support levels, such as the recent March low near $154. The stock's beta of 1.207 indicates it is approximately 21% more volatile than the broader market, which is a critical consideration for risk management, as it implies the stock will typically experience larger swings than the SPY in both directions.
Beta
1.21
1.21x market volatility
Max Drawdown
-19.3%
Largest decline past year
52-Week Range
$124-$198
Price range past year
Annual Return
+45.8%
Cumulative gain past year
| Period | MS Return | S&P 500 |
|---|---|---|
| 1m | +2.0% | +4.0% |
| 3m | +12.3% | +8.2% |
| 6m | +18.7% | +11.5% |
| 1y | +45.8% | +24.3% |
| ytd | +5.9% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MS Fundamental Analysis
Revenue growth has been solid but shows some sequential deceleration; the most recent Q4 2025 revenue was $28.86 billion, representing a year-over-year growth rate of 11.08%. However, this marks a decline from the Q3 2025 revenue of $30.05 billion, indicating a potential peak in the recent cycle, with segment data showing the Wealth Management segment ($8.43B) slightly edging out Institutional Securities ($7.93B) as the largest contributor in the latest period. The growth trajectory suggests the firm is successfully navigating a mixed capital markets environment, with its diversified model providing stability. The company is highly profitable, with Q4 2025 net income of $4.40 billion and a gross margin of 58.02%. Profitability metrics are robust, with a net margin of 14.66% and an operating margin of 19.09%, levels that are strong for a financial services firm. Margins have shown stability, with the gross margin hovering between 54.7% and 58.7% over the last four quarters, indicating effective cost management despite revenue fluctuations, and the firm consistently generates substantial net income each quarter. Balance sheet health is a point of analysis, with a debt-to-equity ratio of 4.26, which is elevated but not uncommon for leveraged financial institutions. The current ratio of 1.17 indicates adequate short-term liquidity. A notable concern is the trailing twelve-month free cash flow of -$17.89 billion, a significant outflow; however, this is heavily influenced by the nature of the banking business (e.g., loan originations, trading book changes) and is not directly comparable to industrial firms. The Return on Equity (ROE) of 15.10% is a strong indicator of efficient capital use and shareholder value creation.
Quarterly Revenue
$28.9B
2025-12
Revenue YoY Growth
+0.11%
YoY Comparison
Gross Margin
+0.58%
Latest Quarter
Free Cash Flow
$-17.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MS Overvalued?
Given the consistent positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 16.54x, while the forward PE is slightly lower at 15.15x. The modest gap between trailing and forward multiples suggests the market anticipates stable, but not dramatically accelerating, earnings growth in the near term. Compared to industry averages, Morgan Stanley trades at a premium based on its Price-to-Sales (PS) ratio of 2.43x, though specific industry average data is not provided in the valuation set for direct quantification. The premium is likely justified by its superior market position, high profitability margins (net margin of 14.66%), and the stable, fee-based nature of its wealth and asset management franchises, which command higher multiples than pure trading or investment banking businesses. Historically, the stock's current trailing PE of 16.54x sits above its own multi-year range observed in the historical ratios data, where it has fluctuated between approximately 8.5x and 24.7x over recent years. Trading near the higher end of this historical band suggests the market is pricing in relatively optimistic expectations for sustained profitability and growth, leaving less room for multiple expansion and increasing sensitivity to any earnings disappointment.
PE
16.5x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 8x~25x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
24.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Morgan Stanley's primary financial risks stem from its leveraged balance sheet and cash flow profile. The debt-to-equity ratio of 4.26, while industry-typical, creates vulnerability to rising funding costs and credit spread widening. The significant negative free cash flow of -$17.89B over the TTM, though partly operational for a bank, requires consistent access to capital markets. Furthermore, revenue showed sequential deceleration from Q3 to Q4 2025, indicating potential cyclical peak risks in its capital markets segments, which could pressure the high net margin of 14.66% if the slowdown persists.
Market & Competitive Risks: The stock trades at a premium valuation with a trailing P/E of 16.54x, near the top of its historical range, creating compression risk if earnings growth fails to meet elevated expectations. Its beta of 1.207 confirms higher volatility and sensitivity to broader market downturns. Competitive risks are inherent in both wealth management (vs. Schwab, Goldman) and investment banking, where fee pressure is constant. Recent news highlights the firm's reliance on capital markets volatility for outsized trading gains, a revenue stream that is inherently unpredictable and could normalize.
Worst-Case Scenario: A severe bear case would involve a simultaneous capital markets downturn and a wealth management outflow event, triggered by a deep recession and sustained market decline. This could lead to significant earnings misses, multiple compression towards the lower end of its historical P/E range, and a test of major technical support. The realistic downside from the current price of $192.51 could be a decline of approximately -35% to retest the 52-week low of $123.88, which would align with the stock's historical max drawdown of -19.28% observed in recent volatility. Such a scenario would likely be accompanied by analyst downgrades and a re-rating of the entire financial sector.
FAQ
The key risks are: 1) Financial Risk: High leverage with a debt-to-equity ratio of 4.26 and significant negative free cash flow of -$17.89B TTM. 2) Cyclical/Market Risk: Revenue is sensitive to capital markets activity, which showed sequential deceleration in Q4 2025; a downturn could pressure earnings. 3) Valuation Risk: Trading near the top of its historical P/E range, the stock is vulnerable to multiple compression if growth disappoints. 4) Operational Risk: Intense competition in both wealth management and investment banking could pressure fees and market share. The most severe near-term risk is the combination of valuation compression and earnings disappointment.
The 12-month forecast for MS presents three scenarios. The Base Case (60% probability) sees the stock trading between $185 and $205, as it consolidates recent gains with stable earnings. The Bull Case (25% probability) targets $210 to $230, driven by a breakout above resistance and stronger capital markets performance. The Bear Case (15% probability) warns of a drop to $140-$165 if a recession hits financials and valuation compresses. The most likely scenario is the Base Case, which assumes the firm executes well but faces cyclical headwinds that limit multiple expansion. The average analyst revenue estimate for the coming year is $93.9 billion.
MS stock is fairly valued. It trades at a forward P/E of 15.15x and a trailing P/E of 16.54x, which is at the higher end of its own historical range. This premium is justified by its superior profitability (net margin 14.66%) and the stable nature of its wealth management business, but it also means there is little room for multiple expansion. Compared to some pure-play investment banks, it may command a premium, but relative to its own history and growth trajectory, the market is paying a fair price for quality, not a discount. The valuation implies the market expects steady mid-single-digit earnings growth and no major disruptions.
MS is a good stock for a long-term, quality-oriented portfolio, but timing is crucial. At its current price near 52-week highs, the immediate risk/reward is balanced, making it less attractive for new money. The stock is a good buy on a pullback towards the $170-$180 range, where the valuation becomes more compelling relative to its strong 15.10% ROE and stable margins. The biggest downside risk is a valuation compression from its current forward P/E of 15.15x if earnings growth stalls. Therefore, it is a good buy for patient investors willing to dollar-cost average or wait for a better entry point.
MS is primarily suitable for a long-term investment horizon of 3-5 years. Its business model is built for compounding wealth management assets and navigating economic cycles, benefits that are best captured over time. The stock's beta of 1.207 and proximity to technical resistance make it less ideal for short-term trading, as it may experience heightened volatility and consolidation. The 2.36% dividend yield also contributes to total return for long-term holders. A minimum holding period of 12-18 months is suggested to allow the investment thesis—based on franchise strength and cyclical recovery—to fully play out.
